Physician profile
David A Gerstenfeld
NPI 1386618098
$2,999.81
in general payments reported to CMS, 2019-2025
16 companies · $419 in 2025
The $419 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $22.42 · 2021: $378 · 2022: $247 · 2023: $367 · 2024: $909 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,067.16 | 2019-2025 | Lensx, Clareon, Unity |
| Johnson & Johnson Surgical Vision, INC. | $160.77 | 2020-2025 | Tecnis Simplicity |
| Tarsus Pharmaceuticals, INC. | $145.81 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $125.67 | 2024-2025 | Oxervate |
| New World Medical,INC. | $123.03 | 2021 | |
| Boston Scientific Corporation | $88.09 | 2024 | |
| Kala Pharmaceuticals, INC. | $63.80 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $55.32 | 2022-2024 | Miebo, Vyzulta |
| Biotissue Holdings INC. | $36.24 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $29.07 | 2021 | |
| Sight Sciences, INC. | $25.43 | 2023 | Tearcare System |
| Eyevance Pharmaceuticals LLC | $19.60 | 2019 | |
| Mallinckrodt Enterprises LLC | $16.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.22 | 2019 | |
| Shire North American Group INC | $13.98 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akorn Operating Company LLC | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gerstenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.